TAKE Solutions' Life Sciences division announced today the release of PharmaReady Version 4.1 that offers new enhancements to the fully integrated, Web-based suite of products.
TAKE Solutions’ Life Sciences Division Announces Release of PharmaReady Version 4.1
Raleigh, N.C. – October 28, 2008 -TAKE Solutions’ Life Sciences division announced today the release of PharmaReady Version 4.1 that offers powerful new enhancements to the fully integrated, web-based suite of products.
The industry-leading document management and submissions publishing solution, built on Microsoft platform, is deployed at customer sites worldwide. “Since its launch in 2003, PharmaReady has been continuously evolving to meet the demands of the regulated life sciences industry. Five years and scores of satisfied customers later, our focus still remains the same,” states Robert MacDougall, Executive Vice President, TAKE Solutions.
With continuous inputs from its customers, TAKE Solutions has been creating newer modules and features to PharmaReady, furthering the effectiveness and easy-of-use of the solution suite. Some of the highlights of the PharmaReady 4.1 are:
PharmaReady V4.1 Highlights:
Document Management System (DMS)
-Virtual Document Workflow and Interface Enhancements
-Enhanced Office 2007 Integration and Support
-Document Owner Functionality and Role
Electronic Submissions (eCTD)
-eCTD Enhanced Support for Canadian STF Submissions
-Increased eCTD Support for STF Sub-Structures
-Enhanced Acrobat Support
-eCTD Submission Compile Time Decrease and Enhancements
-Support for Updated eCTD Guidance from FDA
Training Records Management System (TRMS)
-Option to Add TRMS Events Directly to Outlook Calendar
-Enhanced Action Item Processing
Structured Product Labeling (SPL)
-Workflow Notifications can be turned off / on
-Updated Scripts to Better Support FDA Guidelines
About PharmaReady™PharmaReady is a fully integrated web-based product and services solution suite including Document Management, Training Records Management, Structured Product Labeling and Submission Services. PharmaReady is specifically designed for life science organizations where ease of installation, ease of use, Part 11 compliance, and affordability are the primary business drivers. The PharmaReady solution suite is designed for management of SOPs, work instructions, training records, submission documents and all other documents within business areas regulated by the FDA. PharmaReady is a fully 21 CFR Part 11 compliant solution based on Microsoft Windows technology.
About TAKE Solutions
TAKE Solutions is a leading international business technology company with products backed by a strong domain expertise in Life Sciences and Supply Chain Management, to provide cost-effective, comprehensive solutions for businesses. The vision of the company is to drive industry best practices through our proprietary, in-depth product know-how and solutions that enable business efficiencies for our clients. Since its inception in 2000, TAKE has been serving marquee clients in the Life Sciences and SCM arena. TAKE Solutions conducts business today in 16 countries with more than 300 customers.
Headquartered in Chennai, TAKE has a strong presence in the USA with Life Sciences Domain Excellence centers located in Princeton, New Jersey. TAKE Solutions is assessed at Level 5 of the Capability Maturity Model Integration (CMMI), Software Engineering Institute, Carnegie Mellon University, USA. TAKE Solutions is a Microsoft Gold Certified Partner, a Charter Member of the Microsoft BioIT Alliance, and is a Registered CDISC Solution Provider.www.TAKESolutions.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.